Olean Times Herald

Siemens is the first of many partners to non-exclusively license SpeechDx's speech and clinical dataset with the goal of developing a speech-based bio...

NEW YORK , April 24, 2025 /PRNewswire/ -- The Alzheimer's Drug Discovery Foundation (ADDF) announced today that Mark Roithmayr will retire from his ro...

New findings published in Alzheimer's & Dementia suggest blood biomarkers are expected to become the standard method for diagnosing Alzheimer's, while...

Daniel M. Skovronsky , MD, PhD, of Eli Lilly & Company, Receives Prestigious 2025 Melvin R. Goodes Prize, Nobel Prize of Alzheimer's Research Goodes P...

Skovronsky will be recognized for his extraordinary work with the Amyvid PET scan, the first FDA-approved diagnostic test for Alzheimer's. TheGoodes P...